J. B. Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM.NS

1840.7 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q12016 Q42015 Q42013 Q12012 Q1
Revenue 10,0448,617.38,445.18,817.48,9627,623.27,927.18,094.47,848.16,245.8766,006.565,930.1176,059.8854,917.8115,482.1694,435.6435,222.854,115.4484,286.3254,564.174,461.1033,859.4893,820.2624,353.4263,659.7172,838.3783,062.6193,027.5912,291.6671,848.471
Cost of Revenue 5,474.44,937.22,736.32,981.73,099.7-5,091.22,990.13,015.52,927.82,332.6532,060.322,075.3462,165.4262,104.6051,868.9091,338.2881,862.5571,704.671,503.4781,667.0561,667.4861,888.3171,263.8841,595.1291,315.9881,112.151,132.5671,113.786985.701788.411
Gross Profit 4,569.63,680.15,708.85,835.75,862.312,714.44,9375,078.94,920.33,913.2233,946.243,854.7713,894.4592,813.2063,613.263,097.3553,360.2932,410.7782,782.8472,897.1142,793.6171,971.1722,556.3782,758.2972,343.7291,726.2281,930.0521,913.8051,305.9661,060.06
Gross Profit Ratio 0.4550.4270.6760.6620.6541.6680.6230.6270.6270.6270.6570.650.6430.5720.6590.6980.6430.5860.6490.6350.6260.5110.6690.6340.640.6080.630.6320.570.573
Reseach & Development Expenses 0305.635000319.328000291.07000235.341000193.861000238.84700000000
General & Administrative Expenses 029.12200074.1220001,182.694000400.499000867.866000867.70800000000
Selling & Marketing Expenses 02,077.1780001,807.7780001,249.587000838.212000826.561000817.92900000000
SG&A 2,173.72,106.31,960.81,917.51,487.51,881.91,8061,876.91,338.72,432.2811,194.7061,054.0311,276.2381,238.711846.983810.714886.661,694.427823.158770.217780.5411,685.637722.587737.51674.6400000
Other Expenses 58.9166.373.576.656.345.831.313.48.9-363.0745.278196.441129.742-457.31222.65983.927226.896-407.121163.796185.085126.08-233.393158.20385.52611.17292.7181,457.7221,259.98615.15227.001
Operating Expenses 2,173.72,106.33,817.93,7223,8553,556.23,473.33,514.43,453.52,847.0522,834.8542,744.6932,436.1251,782.6382,077.2562,170.8281,979.021,600.2122,054.3712,058.3671,991.8051,350.3251,923.2032,090.1861,747.3661,558.8351,457.7221,259.986976.726830.785
Operating Income 2,395.91,573.81,964.42,190.32,007.322,7841,4951,577.91,466.81,059.1671,111.3861,110.0781,458.3341,052.8771,536.004926.5271,381.273852.214728.476838.747801.812621.779633.175668.111596.363260.111474.735632.839328.882139.683
Operating Income Ratio 0.2390.1830.2330.2480.2242.9890.1890.1950.1870.170.1850.1870.2410.2140.280.2090.2640.2070.170.1840.180.1610.1660.1530.1630.0920.1550.2090.1440.076
Total Other Income Expenses Net 2.572.2-124.9-103.7-64.3538.9-83-79.6-49.4-26.35531.866184.196120.348267.344548.61566.77189.444-181.979155.264176.346118.04361.051145.23277.883-1.551-7.9122.405-20.98-54.31-171.181
Income Before Tax 2,398.41,6461,839.52,086.61,94323,322.91,4121,498.31,417.41,032.8121,143.2521,294.2741,578.6821,320.2212,084.619993.2971,570.717670.235883.741,015.093919.855682.83778.407745.994594.812252.199474.735632.839274.9358.094
Income Before Tax Ratio 0.2390.1910.2180.2370.2173.0590.1780.1850.1810.1650.190.2180.2610.2680.380.2240.3010.1630.2060.2220.2060.1770.2040.1710.1630.0890.1550.2090.120.031
Income Tax Expense 630.1384.4503.8580.7519.8-210.8351387.5365.4183.069302.078315.398388.088312.12541.779254.062375.663169.526219.27277.462298.742214.927278.894231.281174.10748.52653.244127.47971.67615.009
Net Income 1,768.31,261.5781,335.71,505.91,423.2876.21,0611,110.81,050.3848.451838.86977.5311,188.7321,006.1261,541.066738.2281,194.216501.393662.772936.241620.05466.571498.549513.287420.705203.673421.491505.36203.25443.085
Net Income Ratio 0.1760.1460.1580.1710.1590.1150.1340.1370.1340.1360.140.1650.1960.2050.2810.1660.2290.1220.1550.2050.1390.1210.1310.1180.1150.0720.1380.1670.0890.023
EPS 11.398.228.629.729.25.666.8614.2613.5610.9710.8512.6515.3813.0219.949.5515.456.498.2611.677.736.046.076.145.462.324.685.952.40.51
EPS Diluted 11.398.068.469.549.075.66.7914.2613.5610.9710.8212.6315.3813.0219.949.5515.456.498.2611.677.736.046.076.145.462.324.685.952.40.51
EBITDA 2,803.71,981.22,304.72,5122,377.423,1021,7791,859.21,736.51,266.6971,326.3541,463.8561,766.565795.7241,932.5911,184.9181,781.108847.9941,059.7581,187.6971,085.871804.146937.978900.557752.187403.395596.376757.55364.618130.642
EBITDA Ratio 0.2790.230.2730.2850.2653.030.2240.230.2210.2030.2210.2470.2920.1620.3530.2670.3410.2060.2470.260.2430.2080.2460.2070.2060.1420.1950.250.1590.071